
    
      Primary Efficacy and safety of the procedure in terms of number of remissions, survival,
      event-free survival, relapse risk, and early transplant-related mortality (up to day +100).

      Secondary Graft kinetics (time to neutrophil and platelet recovery after ASCT) 2.Analyze the
      presence of transplant-related complications (infections, sinusoidal occlusive syndrome and
      others) 3.Analyze prognostic factors for engraftment, remission rate, relapse risk,
      disease-free and overall survival after ASCT
    
  